Zacks Investment Management Sutro Biopharma, Inc. Transaction History
Zacks Investment Management
- $10.5 Billion
- Q1 2025
A detailed history of Zacks Investment Management transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 15,143 shares of STRO stock, worth $14,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,143Holding current value
$14,234% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
119Shares Held
60.6MCall Options Held
95.8KPut Options Held
38.5K-
Suvretta Capital Management, LLC New York, NY7.46MShares$7.01 Million0.21% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$6.5 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.44MShares$5.11 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.43MShares$4.17 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$4.13 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $49M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...